The Journal of Urology
Volume 181, Issue 4 , Pages 1550-1557 , April 2009

Genetics and Phenotyping of Urological Chronic Pelvic Pain Syndrome

  • Jordan Dimitrakov

      Affiliations

    • Corresponding Author InformationCorrespondence: Children's Hospital Boston, Enders Research Bldg, Room 1061, 300 Longwood Ave., Boston, Massachusetts 02115 (telephone: 617-919-2521; FAX: 617-249-2035)
    • ,
  • David Guthrie

Received 2 September 2008

References 

  1. Schaeffer AJ. Clinical practice (Chronic prostatitis and the chronic pelvic pain syndrome). N Engl J Med. 2006;355:1690
  2. Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network (U01)National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-07-003.htmlAccessed June 1, 2008.
  3. Krieger J, Nyberg L, Nickel J. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236
  4. Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172:1242
  5. Pontari M. Chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am. 2008;35:81
  6. Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol. 2008;179:1857
  7. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170:810
  8. Keay S, Zhang C, Shoenfelt J, Erickson DR, Whitmore K, Warren JW, et al. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology. 2001;57:9
  9. Hanno P. Re-imagining interstitial cystitis. Urol Clin North Am. 2008;35:91
  10. Blaivas JG, Weiss JP, Desai P, Flisser AJ, Stember DS, Stahl PJ. Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. J Urol. 2005;173:1631
  11. Badenoch AW. Chronic interstitial cystitis. Br J Urol. 1971;43:718
  12. Flood HD, Malhotra SJ, O'Connell HE, Ritchey MJ, Bloom DA, McGuire EJ. Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn. 1995;14:297
  13. Nickel JC. Inflammatory conditions of the male genitourinary tract: prostatitis and related conditions, orchitis, and epididymitis. In:  Wein AJ,  Kavoussi LR,  Novick AC,  Partin AW,  Peters CA editor. Campbell-Walsh Urology. 9th ed.. Philadelphia: Elsevier Saunders; 2006;
  14. Dimitrakov J, Kroenke K, Steers WD, Berde C, Zurakowski D, Freeman MR, et al. Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med. 2007;167:1922
  15. Dimitrakov JD, Kaplan SA, Kroenke K, Jackson JL, Freeman MR. Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Urology. 2006;67:881
  16. Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CA, Nickel JC. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008;71:261
  17. Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V. Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2008;179:956
  18. Warren J, Jackson T, Meyers D, Xu J. Fishbein/Interstitial Cystitis Association (ICA) survey of interstitial cystitis among family members of ICA members: preliminary analysis. Urology. 2001;57:126
  19. Talati A, Ponniah K, Strug LJ, Hodge SE, Fyer AJ, Weissman MM. Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biol Psychiatry. 2008;63:594
  20. Weissman MM, Gross R, Fyer A, Heiman CA, Gareroff MJ, Hodge SE, et al. Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry. 2004;61:273
  21. Hamilton SP, Fyer AJ, Durner M, Heiman GA, Baisre DeLeon A, Hodge SE, et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A. 2003;100:2550
  22. Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49:64
  23. van deMerwe JP, Yamada T, Sakamoto Y. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int J Urol, suppl. 2003;10:S35
  24. Sugaya K, Nishijima S, Yamada T, Miyazato M, Hatano T, Ogawa Y. Molecular analysis of adrenergic receptor genes and interleukin-4/interleukin-4 receptor genes in patients with interstitial cystitis. J Urol. 2002;168:2668
  25. Shoskes DA, Albakri Q, Thomas K, Cook D. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol. 2002;168:331
  26. Nishijima S, Sugaya K, Yamada T, Miyazato M, Ogawa Y. Efficacy of tricyclic antidepressant is associated with beta2-adrenoceptor genotype in patients with interstitial cystitis. Biomed Res. 2006;27:163
  27. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385
  28. Dimitrakov JD. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology. 2001;58:281
  29. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149:465
  30. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161:549
  31. Warren JW, Keay SK, Meyers D, Xu J. Concordance of interstitial cystitis in monozygotic and dizygotic twin pairs. Urology. 2001;57:22
  32. Dimitrakov JD, Boyden SE, Freeman MR, Detchev IY, Tchitalov JI, Kunkel L. Single nucleotide polymorphism (SNP) analysis of autosomal dominant interstitial cystitis: a family-based study. J Urol, suppl. 2005;173:84;abstract 303.
  33. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WE, Ide SE, Di Iorio G, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 1996;274:1197
  34. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehajia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045
  35. Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, et al. Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology. 2003;60:235
  36. Luft FC. Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res. 2003;1:291
  37. Luft FC, Toka O, Toka HR, Jordan J, Bahring S. Mendelian hypertension with brachydactyly as a molecular genetic lesson in regulatory physiology. Am J Physiol Regul Integr Comp Physiol. 2003;285:R709
  38. Luft FC. Present status of genetic mechanisms in hypertension. Med Clin North Am. 2004;88:1
  39. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636
  40. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7:818
  41. Goldman D, Ducci F. Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. Sci World J. 2007;7:124
  42. Jin ZB, Mandai M, Yokota T, Higuchi K, Ohmori K, Ohtsuki F, et al. Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study. J Med Genet. 2008;45:465
  43. Jordan SA, Farrar GJ, Kenna P, Humphries MM, Sheils DM, Kumar-Singh R, et al. Localization of an autosomal dominant retinitis pigmentosa gene to chromosome 7q. Nat Genet. 1993;4:54
  44. Kumar-Singh R, Farrar GJ, Mansergh F, Kenna P, Bhattacharya S, Gal A, et al. Exclusion of the involvement of all known retinitis pigmentosa loci in the disease present in a family of Irish origin provides evidence for a sixth autosomal dominant locus (RP8). Hum Mol Genet. 1993;2:875.

PII: S0022-5347(08)03282-5

doi: 10.1016/j.juro.2008.11.119

The Journal of Urology
Volume 181, Issue 4 , Pages 1550-1557 , April 2009

Article Tools

* Image Usage & Resolution